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Abstract: Three different ionene polymers with varying quaternary ammonium moieties were
used as a proof of concept for the formulation of antisense oligonucleotides, which are capable
of inhibiting Renilla luciferase messenger ribonucleic acid (mRNA). Cationic vesicles, consisting
of cationic polymer, antisense oligonucleotide (Luc) and non-ionic surfactant polysorbate 80, were
investigated regarding their ζ potential, cytotoxicity and transfection efficiency. Deoxyribonucleic
acid- (DNA) forming complexes in the presence of cationic vesicles were also investigated in terms of
small-angle X-ray scattering (SAXS). The studied cationic vesicles showed very little, if any, toxicity
against HeLa cells. Transfection abilities proved to vary strongly depending on the present quaternary
ammonium moiety.
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1. Introduction
The last decades have witnessed a growing interest in the use of synthetic oligonucleotides for
the inhibition of gene expression [1] as an alternative to the classical small molecule drugs to treat
diseases. Examples for such oligonucleotides are antisense oligonucleotides, short interfering RNAs
(siRNAs) [2], aptamers [3], DNA/RNAzymes and antisense-induced exon skipping [4,5]. In order to
achieve the desired inhibition some obstacles must be solved. The first problem to solve is the high
sensitivity of oligonucleotides towards degradation by serum nucleases. This has been partially solved
by the use of chemical modifications of the oligonucleotides at the sugar ring and/or at the phosphate
backbone in order to increase their biostability [6,7]. Cellular uptake of polyanionic oligonucleotides
across the negatively charged cell membrane constitutes another problem. Although it has been shown
that viral vectors are highly efficient for the transfection of plasmid DNA, there are still concerns about
immunogenicity or recombination of oncogenes. Several alternatives for viral transfection methods
have been developed including formulations as a very fast and simple method [8].
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In 1987, Felgner and co-workers reported the first transfection experiment. They used the
cationic lipid N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium (DOTMA) for carrying out an
efficient DNA transfection protocol [9]. Since this, a huge variety of cationic lipids for formulation of
oligonucleotides have been described [10,11]. Even though they comprise promising tools for nucleic
acid delivery there are several aspects to be considered. Cationic lipids have the tendency to interact
with plasma proteins, which has a detrimental effect on transfection efficiency [12]. In addition, high
positive net charge of the formulation can cause toxicity. Therefore a demand for new formulations is
still present. One alternative to cationic lipids is the use of formulations based on cationic polymers
and non-ionic surfactant agents to fine-tune the net charge. Cationic polymers are able to interact with
DNA and RNA molecules with high efficiency and thus generate complexes with a relatively small size.
This particularity makes cationic polymers useful non-viral carriers for improving gene transfection
efficiency [12,13]. Although poly(ethylenimine) (PEI) and poly(L-lysine) (PLL) are the most well-known
and used polymers for gene therapy, the synthesis and efficiency of novel cationic polymers to interact
with nucleic acids in order to mediate cellular uptake have been recently reviewed [13,14].
Ionenes are synthetic polycations with quaternary ammonium functions, which are distributed
along the backbone [15,16]. In general, they can be synthesized by (a) self-polyaddition of aminoalkyl
halides, (b) Menshutkin reaction between bis-tertiary amines and activated dihalide compounds
or (c) via cationic functionalization of precursor polymers [17,18]. Inspired by our results which
described the self-assembly properties of 1,4-diazabicyclo[2.2.2]octane (DABCO) derived ionene [19]
as well as dye uptake [20] and phase-transfer catalysis [21], we decided to take advantage of the
positively charged diammonium moieties present in ionene structures as cationic monomers to
favor the electrostatic interaction process with nucleic acids [22–25]. In this work we have prepared
surfactant-ionene formulations with a series of ionenes made of N,N′-(o-phenylene)dibenzamide (1)
and α,ω-tertiary diamines (Figure 1) with the aim to further study the DNA complexation in terms
of zeta potential, small-angle X-ray scattering (SAXS) and effect of transfection efficiency potency
in antisense technology [1] by studying the ability of the polyplexes depending on the linker length
and flexibility of the polymers to inhibit the Renilla luciferase gene. As mentioned above, the use
of a non-ionic surfactant in the formulation (Tween 80) aims to avoid interactions with plasma
proteins [12] and cell toxicity observed for cationic lipids. Our findings showed that the cationic ionene
polymers formulated with a non-ionic surfactant were not toxic and were able to deliver antisense
oligonucleotides into cells, thereby inhibiting the luciferase expression with promising efficiencies.
These results open new insights on the design of novel ionene-based non-viral carriers for nucleic acids.
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Figure 1. Structures of ionene polymers used in this study with charged diammonium moieties with 
different structures and chain length. 
Figure 1. Structures of ionene polymers used in this study with charged diammonium moieties with
different structures and chain length.
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2. Results and Discussion
2.1. Size and ζ-Potential Measurements
Cationic vesicles containing the respective ionene polymer and polysorbate 80 as a
non-ionic surfactant agent were prepared by the thin-film hydration method in 20 mM of
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HEPES (pH 7.4) buffer solution. A fixed amount
of an antisense oligonucleotide (0.5 µM, Luc) was used to obtain a series of polyplexes at several
N/P ratios (ratio of nitrogen of polymer to phosphate of DNA) that ranged from 0.05 to 6. Finally,
the surface charge was measured in order to determine the overall charge of the preformed ionene
polyplexes in solution.
As depicted in Figure 2, a transition from negative to positive values was clearly observed with
an increase of the ionene concentration of the prepared cationic vesicle formulations. This change
suggested the evidence of electrostatic interactions among negatively charged oligonucleotides and
positively charged vesicles, which led to the formation of the expected ionene-based polyplexes.
Interestingly, we noticed that this transition was different depending on the formulation used. Thus,
in case of DABCO-ionene the formulations reached a positive net charge at N/P ratios ≥1.5; whereas
for C2- and C6-ionene was around ≥0.5, 1 and 4, respectively. All formulations reached a plateau when
the surface charge density was compensated by an increase in the number of cationic polymer chains
in the three systems (N/P ratio of 2, 4 and 6).
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Figure 2. ζ potential of polyplexes at several N/P charge ratios derived from ionene polymers, 
antisense oligonucleotide and polysorbate 80. (A) DABCO-ionene; (B) C2-ionene; (C) C6-ionene. 
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amounts of cationic polymers in the three systems may result in varying the degree of the folding of 
DNA molecules by decreasing the amount of free DNA, therefore leading to an increase in the 
concentration of the negative charge. This effect was primarily observed when the first ionene-based 
polymers were added to these three systems. 
Figure 2. ζ potential of polyplexes at several N/P charge ratios derived from ionene polymers, antisense
oligonucleotide and polysorbate 80. (A) DABCO-ionene; (B) C2-ionene; (C) C6-ionene.
Surprisingly, we observed similar trends in the behavior of the systems when ionene formulations
were added at lower N/P ratios. In particular, an initial decrease in the charge of the complexes was
detected upon the addition of the cationic polymers, followed by a charge increase as described before.
This initial decrease in the charge ratio was also observed and described with other families of cationic
polymers, such as DNA-PEI complexes [26]. Similarly, the presence of initial amounts of cationic
polymers in the three systems may result in varying the degree of the folding of DNA molecules
by decreasing the amount of free DNA, therefore leading to an increase in the concentration of the
negative charge. This effect was primarily observed when the first ionene-based polymers were added
to these three systems.
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2.2. SAXS Measurements
To further investigate the structural information of our preformed ionene polyplexes, solutions of
DNA from salmon testes in 20 mM of HEPES (pH 7.4) were put in contact with two representative
ionene-based vesicle formulations (C2- and C6-ionene). The expected viscous complexes were formed,
separated from the excess solution and washed with deionized water. The first attempts to visualize
the scattered X-ray intensities were unsuccessful because the scattering signal was too weak for both
complexes (data not shown). It is well known that DNA can be compacted by cationic surfactants
forming lipoplexes, which can then co-precipitate at high concentrations to form gels with strong
mechanical properties. When a drop of a concentrated DNA solution is put in contact with a
concentrated cationic surfactant solution, macroscopic films can be obtained that surround the droplet.
Interestingly, these films are quite consistent as they can be cut and opened. Furthermore, the films can
be also dried and rehydrated, preserving their main structural properties as observed by SAXS [27].
Thus, to get better resolution and enhance the signal spectra, the resultant two complexes were further
concentrated by evaporation. This process significantly showed the presence of one peak, which could
be assigned to the pre-formed DNA complexes with C2- and C6-ionene, respectively.
As illustrated in Figure 3A, scattered X-ray intensities of the two ionene complexes showed the
presence of single peaks in which their position did not differ significantly among each other (q = 2.402
and 2.306 nm−1 for polyplexes based on C2- and C6-ionene, respectively). Disappointingly, we were
not able to detect the presence of a second and third peak throughout the spectra, which might confirm
a hexagonal packing of our pre-formed complexes. Additionally, the scattering pattern for the DNA
from salmon testes (without forming complexes) was also included in the spectra for reference as
a control. However, if we assume hexagonal symmetry as observed in lipoplexes [28], the distance
calculated between the centers of the cylinders is 3.0 nm for C2-ionene and 3.1 nm for C6-ionene.
By comparing these results with the DNA complexes made using other kinds of surfactant agents, we
see that both ionene complexes are much more compact. For example, the observed distances between
cylinders were between 4.2 and 4.7 nm in the case of several lipo-amino acid derivatives whereas the
distance for cetyl trimethylamonium bromide (CTAB) and myristyltrimethyl ammonium bromide
(MTAB) were 6.5 and 5.68 nm, respectively [29]). If we tentatively compare these distances with the
dimensions of a DNA double helix (diameter between 2.2 and 2.6 nm [30]), it seems that the structure
of ionene-based complex might pack in a different way. Taking into consideration that DNA chains can
form hexagonal structures intertwined with cationic lipid cylindrical micelles, the observed distances
in the case of ionene complexes suggest diameters of 1.2 and 1.4 nm for C2- and C6-ionene cylinders,
respectively, with a 2:1 hexagonal. These diameters seem reasonable for these molecules.
Finding that SAXS measurements showed polyplex structures formed by the formulation
based on C2- and C6-ionene and DNA salmon testes were similar, the polyplex made of the C6:Luc
oligonucleotide was chosen as a representative compound to carry out the corresponding dynamic
light scattering (DLS) measurements. As illustrated in Figure 3B, polyplexes were formed and showed
an average diameter size of 320 ± 5 nm with good degree of dispersity (0.3). Additionally, polyplexes
based on C6-ionene were characterized by a cryo-scanning electron microscopy (cryo-SEM) (Figure 3C).
The cryo-SEM analysis revealed spherical morphologies of the particles with similar average sizes
(340 nm) than those achieved through the use of DLS, as previously described. These results show
the appropriateness of the use of C6-ionene polymer as a non-viral vehicle for nucleic acids (e.g.,
phosphorothioate and siRNA oligonucleotides).
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Figure 3. (A) Scattered X-ray intensity as a function of scattering vector q at 25 °C. The complex for 
C2-ionene (green) and C6-ionene (blue) are shown together. The scattering pattern produced by the 
salmon testes DNA (black) is also included as a control. The expected positions of second and third 
reflexions for hexagonal packing are shown for C6-ionene as arrows; (B) Representative dynamic 
light scattering DLS measurement of polyplex made of C6:Luc oligonucleotide; (C) Representative 
cryo-scanning electron microscopy image of polyplexes based on C6-ionene.  
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ratios of 2, 4 and 6, respectively. As a control, the effect on the HeLa cells viability of the three 
cationic vesicle formulations (DABCO-ionene, C2-ionene and C6-ionene; mock) without forming 
complexes with Luc, was also tested at 0.6, 1.20 and 3.0 µM (concentrations that were used for the 
preparation of the polyplexes). Cells were incubated with the respective formulations at 37 °C for 24 
h and normalized viabilities of treated cells with regard to untreated cells were measured by using a 
tetrazolium-based colorimetric (MTT) assay [31]. 
As displayed in Figure 4, vesicle formulations that did not contain the Luc oligonucleotide 
showed no cytotoxicity at the three concentrations tested (cellular viabilities >90%). Also, polyplexes 
containing 60 nM of Luc proved to be harmless to the HeLa cells at N/P ratios of 2, 4 and 6, 
respectively. With respect to Luc, the formulations derived from DABCO- and C2-ionene still 
showed perfect nontoxic behavior at concentrations of 300 nM. However, those derived from 
C6-ionene based formulations showed a clear decrease in cell viability with rising N/P ratios (from 
N/P = 4: 78% to N/P = 6: 46%). Additionally, we also evaluated the toxicity caused by the preformed 
lipoplexes based on lipofectamine and the Luc oligonucleotide as controls. As displayed in Figure S1 
(Supporting Information), polyplexes obtained at 60 nM of the Luc oligonucleotide showed low 
toxicity levels whereas the presence of polyplexes obtained at 120 and 300 nM of the Luc 
oligonucleotide was detrimental to cellular viability (55% in both cases). This result confirmed the 
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2.3. Cytotoxicity Assay
Prior to transfection experiments, the cytotoxicity of polyplexes (containing the antisense
oligonucleotide, Luc) derived from the different ionenes was tested on the HeLa cells. Three concentrations
were evaluated (60, 120 and 300 nM) with respect to the Luc oligonucleotide at N/P ratios of 2, 4 and 6,
respectively. As a control, the effect on the HeLa cells viability of the three cationic vesicle formulations
(DABCO-ionene, C2-ionene and C6-ionene; mock) without forming complexes with Luc, was also tested at
0.6, 1.20 and 3.0 µM (concentrations that were used for the preparation of the polyplexes). Cells were
incubated with the respective formulations at 37 ◦C for 24 h and normalized viabilities of treated cells
with regard to untreated cells were measured by using a tetrazolium-based colorimetric (MTT) assay [31].
As displayed in Figure 4, vesicle formulations that did not contain the Luc oligonucleotide
showed no cytotoxicity at the three concentrations tested (cellular viabilities >90%). Also, polyplexes
containing 60 nM of Luc proved to be harmless to the HeLa cells at N/P ratios of 2, 4 and 6, respectively.
With respect to Luc, the formulations derived from DABCO- and C2-ionene still showed perfect
nontoxic behavior at concentrations of 300 nM. However, those derived from C6-ionene based
formulations showed a clear decrease in cell viability with rising N/P ratios (from N/P = 4: 78%
to N/P = 6: 46%). Additionally, we also evaluated the toxicity caused by the preformed lipoplexes
based on lipofectamine and the Luc oligonucleotide as controls. As displayed in Figure S1 (Supporting
Information), polyplexes obtained at 60 nM of the Luc oligonucleotide showed low toxicity levels
whereas the presence of polyplexes obtained at 120 and 300 nM of the Luc oligonucleotide was
Int. J. Mol. Sci. 2017, 18, 1139 6 of 13
detrimental to cellular viability (55% in both cases). This result confirmed the data obtained by
microscopy in which changes in the morphology of the cells were observed after treatment with
lipoplexes at 300 nM (Figure S2).
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2.4. Transfection 
The described ionene-based formulations (DABCO-, C2- and C6-ionene) containing an antisense 
oligonucleotide (Luc), a 17-mer complementary to the mRNA Renilla luciferase gene, have been 
tested regarding their ability of silencing luciferase activity (Figure 5). Generally, cationic particles 
are prone to interact with negatively charged proteins which may initiate aggregation processes 
leading to increasing particle sizes that may abolish the effectiveness of gene transfection [32]. To 
avoid this undesirable effect, initial transfection experiments mediated by ionene formulations were 
evaluated in the absence of serum proteins (Figure 5A). Thus, cationic polyplexes at concentrations 
of 120 nM with respect to Luc oligonucleotide at N/P ratios of 2 and 4 (N/P ratio of 6 was dismissed 
according to MTT data) were prepared. 
Interestingly, two factors influenced the transfection process: the ionene structure and the 
relationship between ionene molar and charge ratio. According to Figure 5A, the use of the DABCO 
ionene-based formulation was detrimental in the transfection at the two N/P ratios tested, possibly 
due to the rigid linker which might have a detrimental effect on complex formation with 
oligonucleotides and therefore a negative effect on mediating nucleic acid delivery. However, 
moderate gene silencing activities were obtained with cationic formulations at a N/P ratio of 4, 
under serum-free conditions at 120 nM with knockdown values of 40% and 27% for C2- and 
C6-ionene, respectively which inhibited luciferase production. This silencing activity, though 
modest, might come from the release and discharge of the Luc oligonucleotide from endosomes, 
most likely by protonation mechanisms [33]. 
Figure 4. Normalized cell viability of polyplexes derived from ionenes, antisense oligonucleotide
and polysorbate 80. Toxicity of cationic vesicles without forming complexes was also tested.
Polyplexes were tested at 60, 120 and 300 nM (concentration of Luc oligonucleotide) with N/P ratios
of 2, 4 and 6. Ionene-based polymers (DABCO, C2 and C6, respectively) without forming polyplexes
were tested at 0.6, 1.2 and 300 µM, respectively). DABCO-ionene = blue color, C2-ionene = red color,
C6-ionene = green color. Each value represents the mean of at least 5 measurements.
2.4. Transfection
The described ionene-based formulations (DABCO-, C2- and C6-ionene) containing an antisense
oligonucleotide (Luc), a 17-mer complementary to the mRNA Renilla luciferase gene, have been tested
regarding their ability of silencing luciferase activity (Figure 5). Generally, cationic particles are prone
to interact with negatively charged proteins which may initiate aggregation processes leading to
increasing particle sizes that may abolish the effectiveness of gene transfection [32]. To avoid this
undesirable effect, initial transfection experiments mediated by ionene formulations were evaluated
in the absence of serum proteins (Figure 5A). Thus, cationic polyplexes at concentrations of 120 nM
with respect to Luc oligonucleotide at N/P ratios of 2 and 4 (N/P ratio of 6 was dismissed according to
MTT data) were prepared.
Interestingly, two factors influenced the transfection process: the ionene structure and the
relationship between ionene molar and charge ratio. According to Figure 5A, the use of the DABCO
ionene-based formulation was detrimental in the transfection at the two N/P ratios tested, possibly due
to the rigid linker which might have a detrimental effect on complex formation with oligonucleotides
and therefore a negative effect on mediating nucleic acid delivery. However, moderate gene silencing
activities were obtained with cationic formulations at a N/P ratio of 4, under serum-free conditions at
120 nM with knockdown values of 40% and 27% for C2- and C6-ionene, respectively which inhibited
luciferase production. This silencing activity, though modest, might come from the release and
discharge of the Luc oligonucleotide from endosomes, most likely by protonation mechanisms [33].
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As C2- and C6-ionene formulations at a N/P ratio of 4 showed the best transfection profile and 
lowest toxicity at 120 nM, they were used for investigating the gene-silencing abilities in the 
presence of 10% fetal bovine serum (FBS) (Figure 5B) and at concentrations of 60, 120 and 300 nM 
with respect to the Luc oligonucleotide. According to the results, transfection efficiencies strongly 
depended upon the presence of the serum, which tended to interact eagerly with our two cationic 
polyplexes. This interaction resulted in decreasing the transfection efficiency of the formulations. 
Thus, while C2- and C6-ionene polyplexes silenced the Renilla luciferase 40 (and 27% at 120 nM in the 
absence of FBS), the presence of FBS was detrimental on inhibiting luciferase at the same 
concentration. Curiously, the values obtained for the two ionenes (C2 and C6) at 120 nM exceeded 
approximately 10–20% of the values obtained for untreated cells (blank) according to the 
dual-luciferase reporter assay. It is undeniable that these results confirm our ionene-based 
polyplexes were not able to impart cellular uptake and therefore inhibit luciferase production at 120 
nM. However, we are unable to demonstrate whether there might have been undesirable 
interactions among the ionene-based polymers and the Renilla/Firefly luciferases at the 
aforementioned concentration. However, it is also noteworthy that this anomalous behavior was 
occasionally observed with other non-viral carriers, such as the proline-rich cell-penetrating 
peptides [34] and carbosilane dendrons [35], as vehicles to transport antisense oligonucleotides.  
When the concentration of the Luc oligonucleotide was increased up to 300 nM, both ionene 
formulations (C2- and C6-ionene) were able to promote gene delivery with similar and significant 
efficiencies (48% and 38% luciferase inhibition for C2- and C6-ionene, respectively) (*** p < 0.001). 
Interestingly, these silencing activities, though similar, were also found to be statistically significant 
in the case of C2-ionene formulations when compared to C6-ionene formulations (* p < 0.05). It seems 
that a medium-sized chain length of the linker has a beneficial effect on the transfection ability; 
perhaps the proper balance between rigidity and flexibility of the polymers must be found for 
optimal effects. Additionally, a scramble (Scr) oligonucleotide complexed with C6-ionene 
formulation at the same N/P ratio of 4 together with C2- and C6-ionene formulations without forming 
polyplexes (mock) were used as controls and did not produce any effect on luciferase inhibition, as 
expected. Finally, to determine the specificity of the gene transfection process, the Luc and Scr 
oligonucleotides (60 nM) were formulated into liposomes as controls (in the presence of 
lipofectamine), obtaining similar inhibition results as previously reported [34] (Supporting 
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Figure 5. Normalized gene-specific silencing activities targeting Renilla luciferase mRNA for polyplex
formulations. (A) In the absence of fetal bovine serum (FBS), at different N/P ratios at 120 nM and
(B) in the presence of FBS at concentrations of 60, 120 and 300 nM. Data are expressed as mean values
of three replicates (±SD); * and *** indicate p < 0.05 and p < 0.001, respectively.
As C2- and C6-ionene formulations at a N/P ratio of 4 showed the best transfection profile
and lowest toxicity at 120 nM, they were used for investigating the gene-silencing abilities in the
presence of 10% fetal bovine serum (FBS) (Figure 5B) and at concentrations of 60, 120 and 300 nM
with respect to the Luc oligonucleotide. According to the results, transfection efficiencies strongly
depended upon the presence of the serum, which tended to interact eagerly with our two cationic
polyplexes. This interactio resulted in decreasing the transfection efficie cy of the formulations.
Thus, while C2- and C6-ion e p lyplexes silenced the Renilla luciferase 40 (and 27% at 120 nM
in the absence of FBS), the presence of FBS was detrimental on inhibiting luciferase at th same
concentration. Curiously, the values obtained for the two ionenes (C2 and C6) at 120 nM exceed d
approximately 10–20% of the values obtaine for untreated cells (blank) according to the dual-luciferase
reporter as ay. It is undeniable th t th se res lts confirm ou ion ne-based polyplexes were not ble to
impart cellular uptake and therefore inhibit luciferase production at 120 nM. Howev r, we ar unable
to demonstrate whether there might have been undesirable interactions among the ionene-bas d
polymers and the Renilla/Firefly lucif rases at the aforementioned concentration. How ver, it is al o
notew rthy that this anomalous behavior was occasionally observed with other non-viral carriers,
such as the proline-rich cell-penetrating peptides [34] and c rbosilane d dr ns [35], as vehicles to
transport antis nse oligonucle tides.
When the concentrati of the Luc oligonucleotide was increased up to 300 nM, both ionene
formulations (C2- and C6-ionene) were a le to promote gene delivery with similar and significant
efficiencies (48% and 38% luciferase inhibition for C2- and C6-ionene, respectively) (*** p < 0.001).
Interestingly, these silencing activities, though similar, were also found to be statistically significant in
the case of C2-ionene formulations when compared to C6-ionene formulations (* p < 0.05). It seems that
a medium-sized chain length of the linker has a beneficial effect on the transfection ability; perhaps
the proper balance between rigidity and flexibility of the polymers must be found for optimal effects.
Additionally, a scramble (Scr) oligonucleotide complexed with C6-ionene formulation at the same
N/P ratio of 4 together with C2- and C6-ionene formulations without forming polyplexes (mock)
were used as controls and did not produce any effect on luciferase inhibition, as expected. Finally, to
determine the specificity of the gene transfection process, the Luc and Scr oligonucleotides (60 nM) were
formulated into liposomes as controls (in the presence of lipofectamine), obtaining similar inhibition
results as previously reported [34] (Supporting Information; Figure S3).
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3. Materials and Methods
3.1. Materials
Polysorbate 80 (Tween 80), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT
reagent), sodium salt of DNA from salmon testes (polymerization average degree of 2000 base pairs)
and antisense oligonucleotide of sequence (5′-CGT TTC CTT TGT TCT GGA-3’; Luc) were purchased
from Sigma-Aldrich (St. Louis, MO, United States) and used as received. A scramble sequence
(5′-CTG TCT GAC GTT CTT TGT-3′; Scr) was synthesized in-house and purified by dimethoxyltrityl,
DMT off-based protocols. Lipofectamine 2000 was purchased from Invitrogen (Carlsbad, CA, USA).
Phosphate-buffered saline (PBS) buffer and Dulbecco’s Modified Eagle’s Medium (DMEM), which
was supplemented with a 10% heat-inactive fetal bovine serum (FBS) along with distilled water
(DNAse/RNAse free) were purchased from Gibco (Waltham, MA, USA). Additional nuclease-free
water was also prepared by using 0.1% of diethylpyrocarbonate (DEPC) to ensure the removal of
RNase contamination, as well as autoclaved and filtered before using. Luciferase assay kits were
purchased from Promega (Madison, WI, United States). Qiagen Giga plasmid purification kit was
purchased from Qiagen (Hilden, Germany). Starting materials for polymer synthesis were purchased
from Sigma Aldrich (St. Louis, MO, USA) or TCI (Zwijndrecht, Belgium). Luminiscence values
were measured in a Promega Glomax Multidetection instrument (Madison, WI, USA). All ionene
polymers were synthesized by step-growth polymerization following the two-step procedure
previously described and showed the same spectroscopic data [19–21,36]. In short, the reaction
of o-phenylenediamine with 4-(chloromethyl)benzoyl chloride in the presence of Et3N in CH2Cl2
afforded the corresponding bis-benzamides in good yields (75–98%). Subsequent copolymerization
with equimolar amounts of the desired α,ω-diamine in dimethylformamide (DMF) at 80 ◦C provided
white precipitates within 2–6 days. The precipitates were filtered, washed (with DMF, CH3CN and
CH2Cl2) and dried under vacuum to afford the ionenes in modest yields (43–80%). Sufficient solubility
for gel permeation chromatography (GPC) was achieved by exchanging the chloride anions by
bis(trifluoromethanesulfonyl)amide (TFSA) anions using lithium bis(trifluoromethanesulfonyl)azanide
(LiTFSA) in hot water. These ionenes·TFSA showed low degrees of polymerization (n = 7–14) and
high dispersity values (Đ = 2.1–3.1). Weight-average molecular weights, Mw (Da), for ionenes·TFSA:
8.1 × 103 (DABCO-ionene); 1.6 × 104 (C2-ionene); 6.9 × 104 (C6-ionene); number-average molecular
weight, Mn (Da), for ionenes·TFSA: 3.9 × 103 (DABCO-ionene); 6.1 × 103 (C2-ionene); 2.2 × 103
(C6-ionene).
3.2. Preparation of Polyplexes
Cationic vesicles were prepared by mixing ionenes (1–2 mg) and polysorbate 80 in a 1:1 (n/n)
molar ratio and dissolving/suspending those in MilliQ water (1 mL). Mixtures were dried in a speed
vacuum at 45 ◦C for 18 h. The resulting film was rehydrated in 1 mL of sterile HEPES buffer (20 mM;
pH 7.4), incubated at 60 ◦C for 20 min, sonicated for 3 min and filtered through a 13 mm nylon filter
with 0.2 µm pore width. Polyplexes were obtained by adding an oligonucleotide stock solution to
the cationic vesicle solutions to give N/P ratios ([cationic amino groups]ionene/[anionic phosphate
groups]nucleic acid) between 0.05 and 8. The mixtures were vortexed, sonicated for 10 s and finally
incubated at 37 ◦C for 30 min.
The synthesized ionene monomers each contained two terminal amine groups that were positively
charged at physiological pH conditions (7.4). The antisense oligonucleotide (Luc oligonucleotide)
contains 17 negative charges and the N/P ratio can be calculated by using Equation (1), as described
elsewhere [37].
N/P ratio =
number of moles of ionene monomer× 2
number of moles of Luc oligonucleotide× 17 (1)
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3.3. Zeta Potential
The zeta potential values were obtained by laser Doppler velocimetry by using a Zetasizer
Nano ZS (Malvern Instruments; Malvern, UK) equipped with a He–Ne red light laser (λ = 633 nm).
Polyplex solutions were measured at an oligonucleotide concentration of 0.5 µM and N/P ratios from
0.05 to 6 at 25 ◦C. Samples (50 µL) were diluted in 0.1 mM NaCl solution (950 µL) and introduced into
folded capillary cells. The Smoluchowski approximation was used to calculate the ζ potential values.
Measurements were run in triplicate.
3.4. Size Measurements
The hydrodynamic diameter of polyplexes (cationic ionene/DNA complexes) was determined
by a dynamic light scattering (DLS) spectrometer (LS Instruments, 3D-cross correlation multiple
scattering) equipped with a He–Ne laser (632.8 nm). Measurements were carried out at a scattering
angle of 90◦, in triplicates at 25 ◦C without sonication. The particle radii were calculated by fitting the
first cumulant parameter.
3.5. Small-Angle X-ray Scattering (SAXS) Measurements of Ionene Polyplexes
Small-angle X-ray scattering measurements were recorded on S3-MICRO (Hecus X-ray system,
GMBH, Graz, Austria) which was coupled to a GENIX-Fox 3D X-ray source (Xenox, Grenoble) and
coupled with a 3D-focusing mirror, which produced a detector-focused X-ray beam with λ = 0.1542 nm
Cu Kα-line (greater than 97% purity and less than 0.3% of Kα). Transmitted scattering was measured
by using a PSD 50 Hecus in the SAXS regime (0.09 nm−1 < q < 6 nm−1) including Bragg peaks
and diffuse scattering. Measurements were carried out at a constant temperature (25 ◦C) for 24 h.
Detector counting was accumulated for 20 min intervals; if no temporal variation was observed,
several runs were summed up to reduce the noise of background level. A stock concentration of
DNA from salmon testes in 20 mM of HEPES (pH 7.4) was properly mixed with a stock concentration
of a surfactant-ionene formulation in 20 mM of HEPES buffer at 37 ◦C for 30 min. The resultant
polyplexes (DNA: ionene complexes) were isolated, dried and deposited in a glass capillary of 1 mm
diameter with 10 µm wall thickness. SAXS scattering curves were plotted as a function of the scattering
vector modulus (Equation (2)) where θ is the scattering angle and λ the incident radiation wavelength.
A silver behenate sample was used in order to calibrate the system scattering vector.
q =
4pi
λ
sin
θ
2
(2)
3.6. Cryo-Scanning Electron Microscopy (cryo-SEM)
Polyplexes made of an ionene-C6 based formulation and the Luc oligonucleotide were obtained
at a N/P ratio of 4. The resultant polyplexes were rapidly frozen in liquid nitrogen and cut with an
equipped cold knife. Polyplexes were sputered with gold palladium, observed and processed by using
a Hitachi S-3500N (Hitachi High-Technologies Corp., Tokyo, Japan) scanning electron microscope
operated at 5 kV.
3.7. Cytotoxicity Assay
The adherent cell line HeLa (human carcinoma) was plated at a density of 5 × 103 cells/well
(50% confluency) on a 96-well plate in 200 µL of Dulbecco’s Modified Eagle’s medium (DMEM),
supplemented with 10% fetal bovine serum (FBS), in the absence of antibiotics. The HeLa cells were
incubated at 37 ◦C in a humidified atmosphere (5% CO2) for 24 h to permit cell attachment. Then the
medium was removed and replaced by fresh one to give a final concentration of 200 µL. Polyplexes
and cationic vesicles were prepared as described above and added to the wells to give concentrations
of 60, 120 and 300 nM and N/P ratios of 2, 4 and 6. The mixture was incubated at 37 ◦C for 18 h,
then the medium was removed and the wells were washed with PBS (1 × 200 µL). Fresh DMEM was
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added (200 µL) and cells were incubated again at 37 ◦C for 3 h. MTT solution (10 µL; 5 g/L in PBS
buffer) was added to each well and plates were stored at 37 ◦C for further 2.5 h. Then medium was
removed, DMSO (100 µL) was added and absorbance was measured at 570 nm. Each measurement
was performed with six replicates. Additionally, to evaluate the effect of lipofectamine in the HeLa
cells, the Luc oligonucleotide was mixed at 60, 120 and 300 nM, respectively at room temperature with
lipofectamine, according to the manufacture’s protocol. HeLa cells and the corresponding lipoplexes
were incubated following the same experimental procedure as described before.
3.8. Gene Transfection and Antisense Technology Studies
3.8.1. In the Absence of FBS
The HeLa cells were regularly passaged to maintain exponential growth. Cells were seeded the
day before at a density of 105 cells/well on a 24-well plate, with each well in DMEM (supplemented
with 10% FBS). Cells were incubated at 37 ◦C for 18 h in a humidified atmosphere (5% CO2) to
permit cell attachment. The medium was then replaced by fresh one (500 µL). A solution containing
firefly luciferase (pGL4) (30 µL; 100 ng/µL) and Renilla luciferase (30 µL; 10 ng/µL) in Opti-MEM™
(90 µL) was combined to a solution containing Lipofectamine 2000 (3.9 µL; 1 mg/mL) in Opti-MEM™
(146.4 µL). The resultant formulation was incubated for 10 min at room temperature. One hundred µL
of this formulation was added to each well and the cells were incubated at 37 ◦C for 6 h. The medium
was removed, the cells were washed with PBS (2 × 400 µL) and DMEM without FBS was added
(500 µL). Polyplexes were added (100 µL) to give final oligonucleotide concentrations of 120 nM and
N/P ratios of 2, 4 and 6 and cells were incubated at 37 ◦C for 24 h. The medium was removed, the
cells were washed with PBS (1 × 500 µL) and the cells were stored at −20 ◦C for 18 h. After thawing
the cells, 100 µL of lysis buffer was added to each well. The plate was shaken at 480 rpm at room
temperature for 15 min. Lysates (25 µL) were transferred to a 96-well plate and luminescence was
recorded after adding, alternatingly, Luciferase assay reagent (25 µL) and Stop & Glow reagent (25 µL).
Inhibition results generated by polyplex-based ionenes were expressed as normalized ratios between
the reported luciferase (Renilla) and control luciferase (Firefly).
3.8.2. In the Presence of FBS
The HeLa cells were regularly passaged to maintain exponential growth. Cells were seeded
the day before at a density of 105 cells/well on a 24-well plate each well in DMEM supplemented
with 10% FBS. The cells were incubated at 37 ◦C for 18 h. The Renilla and Firefly luciferases were
transfected following the same procedure as described above. After 6 h of incubation at 37 ◦C, the
medium was removed, cells were washed with PBS (2 × 400 µL), and DMEM supplemented with
10% FBS was added (500 µL). Polyplexes were added to give a final N/P ratio of 4 and oligonucleotide
concentrations of 60, 120 and 300 nM. The cells were incubated at 37 ◦C for 24 h. The medium was
removed, cells were washed with PBS (1 × 500 µL) and stored at −20 ◦C for 18 h. After thawing the
cells, 100 µL of lysis buffer were added to each well. Luminiscence was measured following the same
protocol as described before. Inhibition results generated by polyplex-based ionenes were expressed
as normalized ratios between the reported luciferase (Renilla) and control luciferase (Firefly). Luc and
Scr oligonucleotides at 60 nM were formulated into liposomes (in the presence of lipofectamine) as
positive and negative controls, respectively.
Statistical Analysis. Data were shown as mean ± standard deviation (SD) and are the result of an
average of three replicates. Statistical differences were determined by using Student’s t-test and were
considered significant when * p < 0.05 and *** p < 0.001.
4. Conclusions
Cationic vesicles derived from ionene polymers with an alternating α,ω-tertiary diamine linker
and the non-ionic surfactant polysorbate 80 were used to entrap oligonucleotide single strands which
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were complementary to Renilla luciferase mRNA. The zeta potential of the vesicle formulations
at different N/P ratios ([cationic amino groups]ionene/[anionic phosphate groups]nucleic acid) was
measured to ensure a positive charge of the system. The MTT assay showed no toxicity for formulations
derived from DABCO- and C2-ionene at several concentrations and N/P ratios (2, 4 and 6) whereas
C6-ionene showed critical cell viabilities at 300 nM with a N/P ratio of 6 (46% of cell viability).
Transfection experiments of all cationic vesicle formulation were investigated by performing a
luciferase activity assay at 120 nM and N/P ratios of 2 and 4 in the absence of proteins. As a
result, DABCO-ionene derived formulations showed no transfection ability at both N/P ratios tested.
The contrast for C2- and C6-ionene derived formulations showed perfect non-toxic behavior, and the
luciferase activity was reduced by 48 and 38% respectively, at a N/P ratio of 4 and Luc concentration
of 300 nM. The use of this complete, harmless formulation at higher concentrations might be an
interesting alternative to current transfection agents. Further structure–activity relationships need
to be carried out in order to obtain optimized cationic ionene derivatives that are less susceptible to
FBS proteins. In addition, further studies to determine the effect of the polymer topology (positional
isomers) on the transfection efficiency are under way in our laboratories and the results will be reported
in due course.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/18/6/
1139/s1.
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